James Michael Keegan, M.D.
Antibiotic Stewardship Program
Antibiotic Stewardship Program
Medical Director Infection Prevention and Epidemiology Clinical
Medical Director, Healthcare Improvement
Medical Director of Hospital Epidemiology and
Professor of Medicine
Pharmacy Specialist, Infectious Diseases
Principal & Founder
Sr. VP, Physician Services and
Dr. James Michael Keegan is an infectious disease specialist with more than 25 years of experience in the medical field and serves as the Antibiotic Stewardship Program Service Line Leader for Pershing Yoakley & Associates (PYA). Throughout his career of practicing medicine, Dr. Keegan has taken an active role in improving the quality of healthcare and patient outcomes by serving in numerous medical director and hospital executive leadership positions. Dr. Keegan has taken special interest in solving the negative impact of the overreliance on broad-spectrum antibiotics and has designed and implemented numerous and successful antibiotic stewardship programs (ASPs) that have shown to reverse the incidence of drug-resistant bacteria.
Dr. Keegan received his medical degree from Emory University, completed his internal medicine residency at University of Tennessee, Chattanooga, and completed his infectious disease fellowship at University of Vermont. He has authored multiple articles and publications related to antibiotic stewardship and other infectious disease-related topics.
Ronald M. Wyatt, M.D., is the medical director in the Division of Healthcare Improvement at The Joint Commission. In this role, Dr. Wyatt promotes quality improvement and patient safety to internal and external audiences, works to influence public policy and legislation for patient safety improvements, and serves as the lead patient safety information and education resource within The Joint Commission. Dr. Wyatt collaborates in the development of National Patient Safety Goals, Sentinel Event Alerts, and Quick Safety publication, and oversees data management and analyses in the Office of Quality and Patient Safety.
Previously, Dr. Wyatt served on the Federal Drug Administration (FDA) Drug Safety Oversight Board, and as a mentor to the Center for Medicare & Medicaid Innovation (CMI) Advisors program at the Centers for Medicare & Medicaid Services.
Dr. Wyatt is a Board-Certified Internist with over 20 years practice experience and is currently licensed in the state of Alabama. He earned his medical degree at the University of Alabama Birmingham and completed residency at the St. Louis University hospital, where he served as Chief Resident in the department of Internal Medicine. Dr. Wyatt earned the Executive Master of Science in Health Administration (MSHA) from The University of Alabama at Birmingham.
Keith S. Kaye, M.D., MPH, serves as the corporate vice president of Quality and Patient Safety, medical director of Hospital Epidemiology and Antimicrobial Stewardship and professor of medicine at Detroit Medical Center and Wayne State University.
Dr. Kaye’s principle research areas of interest include epidemiology of and outcomes associated with multi-drug resistant bacteria; infections in the elderly; surgical site infection; device-related infections and antimicrobial stewardship. As an international leader in infection prevention and antimicrobial stewardship, he is currently the principal investigator on a multi-center, National Institutes of Health contract studying polymyxin-based therapy for infections due to extremely-drug resistant (XDR)-Gram-negative bacilli.
Dr. Kaye received his medical degree from the University of Pennsylvania and completed his internal medicine residency and an infectious diseases fellowship at Beth Israel Deaconess Medical Center in Boston, MA. Dr. Kaye earned a master’s degree in Public Health from the Harvard School of Public Health. He has authored over 170 peer-reviewed articles, 15 book chapters, and has presented numerous abstracts at national conferences.
Dr. Ed Septimus received his medical degree from Baylor College of Medicine in Houston in 1972. Dr. Septimus went on to complete his postgraduate training in internal medicine and infectious diseases at Baylor College of Medicine in Houston. Dr. Ed Septimus is board certified in both internal medicine and infectious diseases. His current position is Medical Director Infection Prevention and Epidemiology Hospital Corporation of America (HCA). He has served on the Board of Directors of the Infectious Diseases Society of America (IDSA) and is on the IDSA Antimicrobial Resistance Committee, the SHEA Antimicrobial Stewardship Committee, and the IDSA Quality Measurement Committee. He was the first recipient of the IDSA Annual Clinician Award. In 2011 he was appointed to the Healthcare-Associated Infections/Preventable Adverse Events Advisory Panel for the Texas Department of State Health Services. He was awarded the John S Dunn Sr. Outstanding Teacher Award in 2010, 2011, 2013 and 2014. He is on the FDA Anti-Infective Drug Advisory Group and is co-chair of the NQF Patient Safety Steering Committee. He holds a faculty position as Clinical Professor at Texas A&M Medical School and Professor, Distinguished Senior Fellow, School of Public Health, George Mason University. He has published over 100 articles and chapters.
Kavita K. Trivedi, M.D. is the founder of Trivedi Consults, LLC and Adjunct Clinical Assistant Professor of Medicine at Stanford University School of Medicine. Dr. Trivedi provides education to healthcare facilities, hospital systems, universities and public health on antimicrobial resistance and antimicrobial stewardship. She also provides consulting services to healthcare facilities and hospital systems on how to implement antimicrobial stewardship programs within resource limitations.
Previously, Dr. Trivedi was the Public Health Medical Officer of the Healthcare Associated Infections Program at California Department of Public Health where she created, managed and led the California Antimicrobial Stewardship Program Initiative. Dr. Trivedi recently served on the antimicrobial resistance working group for the President's Council of Advisors on Science and Technology. She is the author of many publications related to preventing antimicrobial resistance and promoting antimicrobial stewardship.
Dr. Trivedi received her medical degree from Stanford University School of Medicine and completed residency in Internal Medicine at the University of California, San Francisco. She is board certified in Internal Medicine.
T. Clifford Deveny, M.D., is senior vice president, physician services and clinical integration at Catholic Health Initiatives (CHI), the nation's second-largest nonprofit health system. A longtime physician executive, Cliff provides leadership and direction of CHI's employed physician enterprise (3800 providers in 19 states). He is also responsible for CHI Physician Services, a for profit medical services organization as well as CHI’s national clinical service lines. In addition he provides leadership for clinical integration activities including care management and the operations of CHI’s clinically integrated networks. Dr. Deveny formerly served as system vice president, physician alignment and president of Summa Physicians Inc., Akron, Ohio. Board certified in obstetrics and gynecology, Dr. Deveny earned his medical degree from the University of Toledo School of Medicine, Toledo, Ohio.